The global PCR technologies market is anticipated to grow at a considerable CAGR of 5.7% during the forecast period (2022-2028). The growth of the market is largely driven by factors such as increased adoption of PCR testing kits and the presence of key market players. The growth of the market is supported by launches of the approved RT-PCR testing kits and a large number of treatment opportunities in the first-line advanced setting. PCR technologies companies in the market include Abbott Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific, Inc., Eppendorf AG, F. Hoffmann-La Roche AG, GE Healthcare, Illumina, Inc. The PCR test kit has gotten the approval of the FDA for the diagnosis of COVID-19 and other diseases such as cancer, and genetic diseases are expected to fuel the growth of the market.
A full report of Polymerase Chain Reaction (PCR) Technologies Market is available at: https://www.omrglobal.com/industry-reports/polymerase-chain-reaction-pcr-technologies-market
For instance, in November 2020, the US FDA issued Lucira COVID-19 All-In-One Test Kit for self-testing at home and that provides rapid results. The test kit has authorized for home use with self-collected nasal swab samples in individuals age 14 and older who are suspected of COVID-19 by their health care provider. Moreover, in March 2022, Minute Molecular Diagnostics received US FDA approval for DASH (Diagnostic Analyzer for Specific Hybridization). The test uses polymerase chain reaction (PCR) techniques that amplify DNA, increasing incredibly small virus samples to detectable levels.
In addition, in September 2021, Visby Medical announced the approval of instrument-free Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) COVID-19 test by the US FDA for testing pooled patient samples in high-complexity Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories. Through this kit, the laboratories can meet the increasing testing demand by analyzing up to five patients’ samples at once and aids in decreasing the testing cost.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/polymerase-chain-reaction-pcr-technologies-market
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Application
o By Product
o By End User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Abbott laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific, Inc., Eppendorf AG, GE Healthcare, Illumina, Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global PCR Technologies Market Report Segment
By Application
- Research Application
- Clinical Diagnostics Application
- Forensic Application
- Other Application
By Product
- Instruments
- Targeted Therapy
- Immunotherapy
By End User
- Pharmaceutical and Biotechnology Industries
- Clinical Diagnostics Labs and Hospitals
- Academic and Research Organizations
